Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "Gene Editing Markets. By Application, Technology, Place, Industry & Product With Executive And Consultant Guides" report has been added to ResearchAndMarkets.com's offering.
The field of gene editing is experiencing unprecedented advancements, with CRISPR and similar groundbreaking tools revolutionizing biotechnology. Initially spearheaded by medical applications that enabled genetic modifications within living human cells, these technologies have already facilitated the cure of previously untreatable diseases. As these methodologies evolve, the pace of growth is rapidly accelerating, promising further breakthroughs.
Beyond healthcare, gene editing is unlocking vast new opportunities across diverse industries. Every technological breakthrough heralds a new set of applications and prospects, leading to significant innovation in fields ranging from agriculture to environmental science. Companies and researchers are actively exploring the potential of these tools to transform traditional methods and create sustainable solutions for pressing global challenges.
Find out what is expected in the near term and the long term.
The report includes five year market forecasts.
Key Topics Covered:
1 Market Guides
1.1 Strategic Situation Analysis
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
2.1 Methodology
2.2 What is Gene Editing?
2.3 The CRISPR Example
2.4 Chromosomes, Genes and Epigenetics
2.5 Market Definition
2.6 Perspective: Healthcare Spending
3 Market Structure
3.1 Market Structure Therapeutics
3.1.1 Research and Development (R&D) Companies
3.1.2 Biotechnology Companies
3.1.3 Generic Drug Manufacturers
3.1.4 Big Pharmaceuticals
3.1.5 Contract Research Organizations (CROs)
3.1.6 Contract Manufacturing Organizations (CMOs)
3.1.7 Specialty Pharmaceutical Companies
3.1.8 Pharmaceutical Distributors
3.1.9 Retail Pharmacies
3.1.10 Wholesalers
3.1.11 Online Pharmacies
3.1.12 Health Technology Companies
3.1.13 Pharmacy Benefit Managers (PBMs)
3.1.14 Clinical Laboratories
3.1.15 Medical Device Companies
3.1.16 Regulatory Bodies
3.2 Market Structure Diagnostics
3.2.1 Academic Research Lab
3.2.2 Diagnostic Test Developer
3.2.3 Instrumentation Supplier
3.2.4 Chemical/Reagent Supplier
3.2.5 Pathology Supplier
3.2.6 Independent Clinical Laboratory
3.2.7 Public National/regional Laboratory
3.2.8 Hospital Laboratory
3.2.9 Physicians Office Lab (POLS)
3.2.10 Audit Body
3.2.11 Certification Body
4 Market Trends
4.1 Factors Driving Growth
4.1.1 Cell Therapy
4.1.2 Gene Therapy
4.1.3 The New Agriculture
4.1.4 Genetics and Cell Metabolism
4.2 Factors Limiting Growth
5 Recent Developments in Gene Editing
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
5.2 VedaBio Licenses Diagnostic CRISPR Technology
5.3 YolTech Therapeutics Raises $45 Million in Series B Funding
5.4 Prime Editing Breakthrough Corrects Genetic Deficiency
5.5 Arbor Biotechnologies Announces First Patient Dosed
5.6 CRISPR Therapeutics Reports Positive Data for Liver-Targeted Therapy
5.7 Lilly to acquire Verve Therapeutics
5.8 Personalized CRISPR Therapy for Infant with Rare Genetic Disease
5.9 New CRISPR Diagnostic Test Detects Pathogens Without Amplification
5.10 OraSure Technologies Acquires Sherlock Biosciences
5.11 CRISPR tool allows for remote-controlled gene-editing
5.12 CRISPR Making Sweeter Tomatoes
5.13 Researchers Create gene-edited prawns
5.14 Gene Editing Corrects Cystic Fibrosis
5.15 Gene Editing Reverses Heart Disease In Mice
5.16 CRISPR gene editing to change healthcare?
5.17 CRISPRBits Collaborates With MolBio Diagnostics
5.18 Sherlock Bioscience to Launch Free AI-Based Operating System
5.19 Sherlock Biosciences to Acquire Sense Biodetection
5.20 CRISPR Enzyme Discovery Opens New Applications
5.21 Sherlock Biosciences Adds Ambient Amplification to Toolkit
5.22 Rice University Adapts CRISPR Enzyme
5.23 Princeton Group Develops Cas13 Assay for Point-of-Care Use
5.24 Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
5.25 Sherlock Biosciences Raises $80M
5.26 Broad Institute Considers CRISPR Respiratory Panels to Replace PCR
5.27 Medix Biochemica Acquires MyPols Biotec
5.28 Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets EUA
6 Key Companies
6.1 Key Companies - Importance and How to Use This Section
6.1.1 Importance of These Players
6.1.2 How to Use This Section
6.2 10x Genomics, Inc.
6.3 4D Molecular Therapeutics
6.4 Abeona Therapeutics
6.5 Acrigen Biosciences
6.6 Adarx Pharmaceuticals
6.7 Adverum Biotechnologies
6.8 Affini-T Therapeutics
6.9 Agilent
6.10 Arbor Biotechnologies
6.11 Arcturus Therapeutics
6.12 Axxam
6.13 Beam Therapeutics
6.14 Beckman Coulter Diagnostics (Danaher)
6.15 Becton, Dickinson and Company
6.16 Binx Health
6.17 bioMerieux Diagnostics
6.18 Bio-Rad Laboratories, Inc
6.19 Bluebird Bio
6.20 Caribou Biosciences
6.21 Cell Microsystems
6.22 Cellenion (BICO)
6.23 Century Therapeutics
6.24 Chroma Medicine
6.25 Creative Biogene
6.26 CRISPR Therapeutics
6.27 Editas Medicine
6.28 ERS Genomics
6.29 FASMAC
6.30 Genscript Biotech
6.31 Illumina
6.32 Inscripta
6.33 Intellia Therapeutics
6.34 J&J Innovative Medicine
6.35 Locus Biosciences
6.36 Mammoth Biosciences
6.37 Metagenomi
6.38 Myllia Biotechnology
6.39 Namocell
6.40 NRGene
6.41 Oxford Biomedica
6.42 Poseida Therapeutics
6.43 Precision Biosciences
6.44 Prime Medicine
6.45 Proof Diagnostics
6.46 Regeneron Pharmaceuticals
6.47 Revvity
6.48 Roche Diagnostics
6.49 Sangamo Therapeutics
6.50 Sherlock Biosciences
6.51 Thermo Fisher Scientific
6.52 Twist Bioscience
6.53 VedaBio
6.54 Verve Therapeutics
6.55 Vivlion
6.56 Wave Life Science
7 The Global Market for Gene Editing
7.1 Global Market Overview by Country
7.2 Global Market by Application
7.3 Global Market Technology
7.4 Global Market Type
7.5 Global Market Industry
7.6 Global Market Product
8 Gene Editing Markets - By Application
8.1 Cell Line
8.2 Plant
8.3 Animal
8.4 Celll Therapy
8.5 Gene Therapy
8.6 Diagnostics
8.7 Research
8.8 Other Application
9 Global Gene Editing Markets - by Technology
9.1 CRISPR
9.2 Talens
9.3 ZFN
9.4 Meganuclease
9.5 Other Technology
10 Gene Editing Markets - by Place
10.1 In Vivo
10.2 Ex Vivo
10.3 In Vitro
11 Gene Editing Markets - by Industry
11.1 Pharma
11.2 Clinical
11.3 Academic
11.4 Contract
11.5 Other Industry
12 Global Gene Editing Markets - by Product
12.1 Instruments
12.2 Cells
12.3 Reagents
12.4 Other Product
13 Appendices
13.1 United States Medicare System: Laboratory Fees Schedule
13.2 The Most Used IVD Assays
13.3 The Highest Grossing Assays
13.4 Global Listing of Sequencing Establishments - Location & Contacts
For more information about this report visit https://www.researchandmarkets.com/r/b2xhou
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
